SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Astria Therapeutics, Inc. – ‘10-Q’ for 3/31/22 – ‘EX-10.7’

On:  Thursday, 5/12/22, at 4:00pm ET   ·   For:  3/31/22   ·   Accession #:  1104659-22-59405   ·   File #:  1-37467

Previous ‘10-Q’:  ‘10-Q’ on 11/10/21 for 9/30/21   ·   Next:  ‘10-Q’ on 8/9/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 5/9/24 for 3/31/24   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/12/22  Astria Therapeutics, Inc.         10-Q        3/31/22   66:5.6M                                   Toppan Merrill/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    670K 
 2: EX-10.5     Material Contract                                   HTML     37K 
 3: EX-10.6     Material Contract                                   HTML     36K 
 4: EX-10.7     Material Contract                                   HTML     48K 
 5: EX-10.8     Material Contract                                   HTML     71K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     24K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     24K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
14: R1          Document and Entity Information                     HTML     72K 
15: R2          Condensed Consolidated Balance Sheets               HTML    106K 
16: R3          Condensed Consolidated Balance Sheets               HTML     40K 
                (Parenthetical)                                                  
17: R4          Condensed Consolidated Statements of Operations     HTML     69K 
18: R5          Condensed Consolidated Statements of Comprehensive  HTML     42K 
                Loss                                                             
19: R6          Condensed Consolidated Statements of Comprehensive  HTML     21K 
                Loss (Parenthetical)                                             
20: R7          Condensed Consolidated Statements of Redeemable     HTML     35K 
                Convertible Preferred Stock and Stockholders'                    
                Equity - Mezzanine Equity                                        
21: R8          Condensed Consolidated Statements of Redeemable     HTML     64K 
                Convertible Preferred Stock and Stockholders'                    
                Equity                                                           
22: R9          Condensed Consolidated Statements of Cash Flows     HTML     76K 
23: R10         Organization and Operations                         HTML     48K 
24: R11         Summary of Significant Accounting Policies          HTML     53K 
25: R12         Acquisition of Quellis                              HTML     31K 
26: R13         Financial Instruments                               HTML    123K 
27: R14         Short-Term Investments                              HTML     77K 
28: R15         Accrued Expenses                                    HTML     35K 
29: R16         Commitments                                         HTML     30K 
30: R17         Stockholders' Equity                                HTML     48K 
31: R18         Reserved for Future Issuance                        HTML     33K 
32: R19         Stock Incentive Plans                               HTML     53K 
33: R20         Subsequent Events                                   HTML     22K 
34: R21         Summary of Significant Accounting Polices           HTML     70K 
                (Polices)                                                        
35: R22         Organization and Operations (Tables)                HTML     35K 
36: R23         Summary of Significant Accounting Policies          HTML     44K 
                (Tables)                                                         
37: R24         Acquisition of Quellis (Tables)                     HTML     28K 
38: R25         Financial Instruments (Tables)                      HTML    119K 
39: R26         Short-Term Investments (Tables)                     HTML     75K 
40: R27         Accrued Expenses (Tables)                           HTML     34K 
41: R28         Commitments (Tables)                                HTML     28K 
42: R29         Stockholders' Equity (Tables)                       HTML     43K 
43: R30         Reserved for Future Issuance (Tables)               HTML     37K 
44: R31         Stock Incentive Plans (Tables)                      HTML     51K 
45: R32         Organization and Operations - Reverse Stock Split,  HTML     50K 
                Agreement and Plan of Merger (Details)                           
46: R33         Organization and Operations - Stock Purchase        HTML     83K 
                Agreement and Series X Preferred Stock (Details)                 
47: R34         Organization and Operations - Liquidity (Details)   HTML     35K 
48: R35         Summary of Significant Accounting Policies - Net    HTML     32K 
                Loss Per Share (Details)                                         
49: R36         Summary of Significant Accounting Policies - Cash,  HTML     29K 
                Cash Equivalents and Restricted Cash (Details)                   
50: R37         Summary of Significant Accounting Policies -        HTML     31K 
                Preferred Stock Discount (Details)                               
51: R38         Acquisition of Quellis (Details)                    HTML     42K 
52: R39         Acquisition of Quellis - Net assets acquired based  HTML     34K 
                on their estimated fair values (Details)                         
53: R40         Financial Instruments - Fair value hierarchy        HTML     58K 
                (Details)                                                        
54: R41         Short-Term Investments (Details)                    HTML     47K 
55: R42         Accrued Expenses (Details)                          HTML     31K 
56: R43         Commitments (Details)                               HTML     35K 
57: R44         Stockholders' Equity - Preferred Stock (Details)    HTML     33K 
58: R45         Stockholders' Equity - Outstanding Warrants         HTML     34K 
                (Details)                                                        
59: R46         Reserved for Future Issuance (Details)              HTML     32K 
60: R47         Stock Incentive Plans - Stock options (Details)     HTML     73K 
61: R48         Stock Incentive Plans - Inducement Plan (Details)   HTML     27K 
64: XML         IDEA XML File -- Filing Summary                      XML    111K 
62: XML         XBRL Instance -- atxs-20220331x10q_htm               XML   1.21M 
63: EXCEL       IDEA Workbook of Financial Reports                  XLSX     64K 
10: EX-101.CAL  XBRL Calculations -- atxs-20220331_cal               XML    111K 
11: EX-101.DEF  XBRL Definitions -- atxs-20220331_def                XML    455K 
12: EX-101.LAB  XBRL Labels -- atxs-20220331_lab                     XML    842K 
13: EX-101.PRE  XBRL Presentations -- atxs-20220331_pre              XML    637K 
 9: EX-101.SCH  XBRL Schema -- atxs-20220331                         XSD    121K 
65: JSON        XBRL Instance as JSON Data -- MetaLinks              262±   391K 
66: ZIP         XBRL Zipped Folder -- 0001104659-22-059405-xbrl      Zip    193K 


‘EX-10.7’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  C:  <!  <> 

Exhibit 10.7

A picture containing text, clipart

Description automatically generated

ASTRIA THERAPEUTICS, INC.

2015 EMPLOYEE STOCK PURCHASE PLAN*

The purpose of this Plan is to provide eligible employees of Astria Therapeutics, Inc. (the “Company”) and certain of its subsidiaries with opportunities to purchase shares of the Company’s common stock, $0.001 par value (the “Common Stock”), commencing at such time as the Company’s Board of Directors (the “Board”) shall determine. Subject to adjustment under Section 15 hereof, the number of shares of Common Stock that have been approved for this purpose is the sum of:

(a)3,039 shares of Common Stock; plus

(b)an annual increase to be added on the first day of each fiscal year, commencing on January 1, 2016 and ending on December 31, 2026, equal to the least of (i) 6,078 shares of Common Stock, (ii) 1% of the outstanding shares on such date and (iii) an amount determined by the Board.

This Plan is intended to qualify as an “employee stock purchase plan” as defined in Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”), and the regulations issued thereunder, and shall be interpreted consistent therewith.

1.Administration. The Plan will be administered by the Board or by a Committee appointed by the Board (the “Committee”). The Board or the Committee has authority to make rules and regulations for the administration of the Plan and its interpretation and decisions with regard thereto shall be final and conclusive.

2.Eligibility. All employees of the Company and all employees of any subsidiary of the Company (as defined in Section 424(f) of the Code) designated by the Board or the Committee from time to time (a “Designated Subsidiary”), are eligible to participate in any one or more of the offerings of Options (as defined in Section 9) to purchase Common Stock under the Plan provided that:

(a)they are customarily employed by the Company or a Designated Subsidiary for more than 20 hours a week and for more than five months in a calendar year;

(b)they have been employed by the Company or a Designated Subsidiary for at least six (6) months prior to enrolling in the Plan; and

(c)they are employees of the Company or a Designated Subsidiary on the first day of the applicable Plan Period (as defined below).

No employee may be granted an Option hereunder if such employee, immediately after the Option is granted, owns 5% or more of the total combined voting power or value of the stock of the Company or any subsidiary. For purposes of the preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of an employee,

- 1 -


A picture containing text, clipart

Description automatically generated

and all stock that the employee has a contractual right to purchase shall be treated as stock owned by the employee.

The Company retains the discretion to determine which eligible employees may participate in an offering pursuant to and consistent with Treasury Regulation Sections 1.423-2(e) and (f).

3.Offerings. The Company will make one or more offerings (“Offerings”) to employees to purchase stock under this Plan. Offerings will begin at such time as the Board shall determine. Each Offering will consist of a six-month period (a “Plan Period”) during which payroll deductions will be made and held for the purchase of Common Stock at the end of the Plan Period. The Board or the Committee may, at its discretion, choose a different Plan Period of not more than twelve (12) months for subsequent Offerings.

4.Participation. An employee eligible on the first day of any Plan Period of any Offering may participate in such Offering by completing and forwarding either a written or electronic payroll deduction authorization form to the employee’s appropriate payroll office at least 15 days prior to the commencement of the applicable Plan Period. The form will authorize a regular payroll deduction from the Compensation received by the employee during the Plan Period. Unless an employee files a new form or withdraws from the Plan, his or her deductions and purchases will continue at the same rate for future Offerings under the Plan as long as the Plan remains in effect. The term “Compensation” means the amount of money reportable on the employee’s Federal Income Tax Withholding Statement, excluding overtime, shift premium, incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances for travel expenses, income or gains associated with the grant or vesting of restricted stock, income or gains on the exercise of Company stock options or stock appreciation rights, and similar items, whether or not shown or separately identified on the employee’s Federal Income Tax Withholding Statement but including, in the case of salespersons, sales commissions to the extent determined by the Board or the Committee.

5.Deductions. The Company will maintain payroll deduction accounts for all participating employees. With respect to any Offering made under this Plan, an employee may authorize a payroll deduction in any percentage amount up to a maximum of 15% (in whole percentages) of the Compensation he or she receives during the Plan Period or such shorter period during which deductions from payroll are made. The Board or the Committee may, at its discretion, designate a lower maximum contribution rate. The minimum payroll deduction is such percentage of Compensation as may be established from time to time by the Board or the Committee.

6.Deduction Changes. An employee may decrease or discontinue his or her payroll deduction once during any Plan Period, by filing either a written or electronic new payroll deduction authorization form. However, an employee may not increase his or her payroll deduction during a Plan Period. If an employee elects to discontinue his or her payroll deductions during a Plan Period, but does not elect to withdraw his or her funds pursuant to Section 8 hereof, funds deducted prior to his election to discontinue will be applied to the purchase of Common Stock on the Exercise Date (as defined below).

- 2 -


A picture containing text, clipart

Description automatically generated

7.Interest. Interest will not be paid on any employee accounts, except to the extent that the Board or the Committee, in its sole discretion, elects to credit employee accounts with interest at such rate as it may from time to time determine.

8.Withdrawal of Funds. An employee may at any time prior to the close of business on the fifteenth business day prior to the end of a Plan Period and for any reason permanently draw out the balance accumulated in the employee’s account and thereby withdraw from participation in an Offering. Partial withdrawals are not permitted. The employee may not begin participation again during the remainder of the Plan Period during which the employee withdrew his or her balance. The employee may participate in any subsequent Offering in accordance with terms and conditions established by the Board or the Committee.

9.Purchase of Shares.

(a)Number of Shares.On the first day of each Plan Period, the Company will grant to each eligible employee who is then a participant in the Plan an option (an “Option”) to purchase on the last business day of such Plan Period (the “Exercise Date”) at the applicable purchase price (the “Option Price”) up to that whole number of shares of Common Stock determined by multiplying $2,083 by the number of full months in the Plan Period and dividing the result by the closing price (as determined below) on the first day of such Plan Period; provided, however, that no employee may be granted an Option which permits his or her rights to purchase Common Stock under this Plan and any other employee stock purchase plan (as defined in Section 423(b) of the Code) of the Company and its subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such Common Stock (determined at the date such Option is granted) for each calendar year in which the Option is outstanding at any time.

(b)Option Price.The Board or the Committee shall determine the Option Price for each Plan Period, including whether such Option Price shall be determined based on the lesser of the closing price of the Common Stock on (i) the first business day of the Plan Period or (ii) the Exercise Date, or shall be based solely on the closing price of the Common Stock on the Exercise Date; provided, however, that such Option Price shall be at least 85% of the applicable closing price. In the absence of a determination by the Board or the Committee, the Option Price will be 85% of the lesser of the closing price of the Common Stock on (i) the first business day of the Plan Period and (ii) the Exercise Date. The closing price shall be (a) the closing price (for the primary trading session) on any national securities exchange on which the Common Stock is listed or (b) the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in The Wall Street Journal or another source selected by the Board or the Committee. If no sales of Common Stock were made on such a day, the price of the Common Stock shall be the reported price for the next preceding day on which sales were made.

(c)Exercise of Option.Each employee who continues to be a participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option at the Option Price on such date and shall be deemed to have purchased from the Company the number of whole shares of Common Stock reserved for the purpose of the Plan that his or her accumulated payroll deductions on such date will pay for, but not in excess of the maximum numbers determined in the manner set forth above.

- 3 -


A picture containing text, clipart

Description automatically generated

(d)Return of Unused Payroll Deductions. Any balance remaining in an employee’s payroll deduction account at the end of a Plan Period will be automatically refunded to the employee, except that any balance that is less than the purchase price of one share of Common Stock will be carried forward into the employee’s payroll deduction account for the following Offering, unless the employee elects not to participate in the following Offering under the Plan, in which case the balance in the employee’s account shall be refunded.

10.Issuance of Certificates. Certificates representing shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or (in the Company’s sole discretion) in the name of a brokerage firm, bank, or other nominee holder designated by the employee. The Company may, in its sole discretion and in compliance with applicable laws, authorize the use of book entry registration of shares in lieu of issuing stock certificates.

11.Rights on Retirement, Death or Termination of Employment. If a participating employee's employment ends before the last business day of a Plan Period, no payroll deduction shall be taken from any pay then due and owing to the employee and the balance in the employee’s account shall be paid to the employee. In the event of the employee’s death before the last business day of a Plan Period, the Company shall, upon notification of such death, pay the balance of the employee’s account (a) to the executor or administrator of the employee’s estate or (b) if no such executor or administrator has been appointed to the knowledge of the Company, to such other person(s) as the Company may, in its discretion, designate. If, before the last business day of the Plan Period, the Designated Subsidiary by which an employee is employed ceases to be a subsidiary of the Company, or if the employee is transferred to a subsidiary of the Company that is not a Designated Subsidiary, the employee shall be deemed to have terminated employment for the purposes of this Plan.

12.Optionees Not Stockholders. Neither the granting of an Option to an employee nor the deductions from his or her pay shall make such employee a stockholder of the shares of Common Stock covered by an Option under this Plan until he or she has purchased and received such shares.

13.Options Not Transferable. Options under this Plan are not transferable by a participating employee other than by will or the laws of descent and distribution, and are exercisable during the employee’s lifetime only by the employee.

14.Application of Funds. All funds received or held by the Company under this Plan may be combined with other corporate funds and may be used for any corporate purpose.

15.Adjustment for Changes in Common Stock and Certain Other Events.

(a)Changes in Capitalization. In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any dividend or distribution to holders of Common Stock other than an ordinary cash dividend, (i) the number and class of securities available under this Plan, (ii) the share limitations set forth in Section 9, and (iii) the Option

- 4 -


A picture containing text, clipart

Description automatically generated

Price shall be equitably adjusted to the extent determined by the Board or the Committee.

(b)Reorganization Events.

(1)Definition. A “Reorganization Event” shall mean: (a) any merger or consolidation of the Company with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b) any transfer or disposition of all of the Common Stock of the Company for cash, securities or other property pursuant to a share exchange or other transaction or (c) any liquidation or dissolution of the Company.

(2)Consequences of a Reorganization Event on Options. In connection with a Reorganization Event, the Board or the Committee may take any one or more of the following actions as to outstanding Options on such terms as the Board or the Committee determines: (i) provide that Options shall be assumed, or substantially equivalent Options shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) upon written notice to employees, provide that all outstanding Options will be terminated immediately prior to the consummation of such Reorganization Event and that all such outstanding Options will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Board or the Committee in such notice, which date shall not be less than ten (10) days preceding the effective date of the Reorganization Event, (iii) upon written notice to employees, provide that all outstanding Options will be cancelled as of a date prior to the effective date of the Reorganization Event and that all accumulated payroll deductions will be returned to participating employees on such date, (iv) in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the “Acquisition Price”), change the last day of the Plan Period to be the date of the consummation of the Reorganization Event and make or provide for a cash payment to each employee equal to (A) (1) the Acquisition Price times (2) the number of shares of Common Stock that the employee’s accumulated payroll deductions as of immediately prior to the Reorganization Event could purchase at the Option Price, where the Acquisition Price is treated as the fair market value of the Common Stock on the last day of the applicable Plan Period for purposes of determining the Option Price under Section 9(b) hereof, and where the number of shares that could be purchased is subject to the limitations set forth in Section 9(a), minus (B) the result of multiplying such number of shares by such Option Price, (v) provide that, in connection with a liquidation or dissolution of the Company, Options shall convert into the right to receive liquidation proceeds (net of the Option Price thereof) and (vi) any combination of the foregoing.

For purposes of clause (i) above, an Option shall be considered assumed if, following consummation of the Reorganization Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the

- 5 -


A picture containing text, clipart

Description automatically generated

consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of such number of shares of common stock of the acquiring or succeeding corporation (or an affiliate thereof) that the Board determines to be equivalent in value (as of the date of such determination or another date specified by the Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event.

16.Amendment of the Plan. The Board may at any time, and from time to time, amend or suspend this Plan or any portion thereof, except that (a) if the approval of any such amendment by the shareholders of the Company is required by Section 423 of the Code, such amendment shall not be effected without such approval, and (b) in no event may any amendment be made that would cause the Plan to fail to comply with Section 423 of the Code.

17.Insufficient Shares. If the total number of shares of Common Stock specified in elections to be purchased under any Offering plus the number of shares purchased under previous Offerings under this Plan exceeds the maximum number of shares issuable under this Plan, the Board or the Committee will allot the shares then available on a pro-rata basis.

18.Termination of the Plan. This Plan may be terminated at any time by the Board. Upon termination of this Plan all amounts in the accounts of participating employees shall be promptly refunded.

19.Governmental Regulations. The Company’s obligation to sell and deliver Common Stock under this Plan is subject to listing on a national stock exchange (to the extent the Common Stock is then so listed or quoted) and the approval of all governmental authorities required in connection with the authorization, issuance or sale of such stock.

20.Governing Law. The Plan shall be governed by Delaware law except to the extent that such law is preempted by federal law.

21.Issuance of Shares. Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source.

22.Notification upon Sale of Shares. Each employee agrees, by entering the Plan, to promptly give the Company notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased.

23.Grants to Employees in Foreign Jurisdictions. The Company may, to comply with the laws of a foreign jurisdiction, grant Options to employees of the Company or a Designated Subsidiary who are citizens or residents of such foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of Section 7701(b)(1)(A) of the Code)) with terms that are less favorable (but not more favorable) than the terms of Options granted under the Plan to employees of the Company or a Designated

- 6 -


A picture containing text, clipart

Description automatically generated

Subsidiary who are resident in the United States. Notwithstanding the preceding provisions of this Plan, employees of the Company or a Designated Subsidiary who are citizens or residents of a foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of Section 7701(b)(1)(A) of the Code)) may be excluded from eligibility under the Plan if (a) the grant of an Option under the Plan to a citizen or resident of the foreign jurisdiction is prohibited under the laws of such jurisdiction or (b) compliance with the laws of the foreign jurisdiction would cause the Plan to violate the requirements of Section 423 of the Code. The Company may add one or more appendices to this Plan describing the operation of the Plan in those foreign jurisdictions in which employees are excluded from participation or granted less favorable Options.

25.Authorization of Sub-Plans. The Board may from time to time establish one or more sub-plans under the Plan with respect to one or more Designated Subsidiaries, provided that such sub-plan complies with Section 423 of the Code.

26.Withholding. If applicable tax laws impose a tax withholding obligation, each affected employee shall, no later than the date of the event creating the tax liability, make provision satisfactory to the Board for payment of any taxes required by law to be withheld in connection with any transaction related to Options granted to or shares acquired by such employee pursuant to the Plan. The Company may, to the extent permitted by law, deduct any such taxes from any payment of any kind otherwise due to an employee.

27.Effective Date and Approval of Shareholders. The Plan shall become effective upon the closing of our initial public offering.

* Reflects the name change from Catabasis Pharmaceuticals, Inc. to Astria Therapeutics, Inc. effective September 8, 2021, and the reverse stock splits effective on June 11, 2015, December 28, 2018, and August 19, 2021.

- 7 -



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
12/31/26
Filed on:5/12/22S-3
For Period end:3/31/22
9/8/218-K
8/19/218-K
12/28/188-K
1/1/16
6/11/15S-1/A
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/04/24  Astria Therapeutics, Inc.         10-K       12/31/23   80:11M                                    Toppan Merrill/FA2
 3/22/23  Astria Therapeutics, Inc.         10-K       12/31/22   79:8.2M                                   Toppan Merrill/FA
12/15/22  Astria Therapeutics, Inc.         424B5                  1:464K                                   Toppan Merrill/FA
11/10/22  Astria Therapeutics, Inc.         424B5                  1:313K                                   Toppan Merrill/FA
 9/16/22  Astria Therapeutics, Inc.         424B5                  1:317K                                   Toppan Merrill/FA
 5/13/22  Astria Therapeutics, Inc.         S-3                    4:805K                                   Toppan Merrill/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/10/22  Astria Therapeutics, Inc.         10-K       12/31/21   78:12M                                    Toppan Merrill/FA
 2/22/22  Astria Therapeutics, Inc.         8-K:5,9     2/17/22   12:339K                                   Toppan Merrill/FA
Top
Filing Submission 0001104659-22-059405   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 8:18:40.1pm ET